SLV308 for Treatment of Patients With Early Parkinson's Disease

Clinical trial NCT00269516 · COMPLETED

Trial details

NCT number: NCT00269516
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Stage Parkinson's Disease

Start date: 2006-06-01
Primary completion: 2007-12-01
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.